Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MonoPepT1De: Proinsulin Peptide Immunotherapy in New-Onset Type 1 Diabetes
NCT01536431Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Jan 2012
- Primary completion
- Feb 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Proinsulin C19-A3 peptide in type 1 diabetes mellitus (T1D), sponsored by Cardiff University. Started Jan 2012; status: completed.
02
Drugs
Proinsulin C19-A3 peptide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01536431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536431.